The QualityStocks Daily Friday, January 9th, 2026

Today's Top 3 Investment Newsletters

InsiderTrades(ZNTL) $3.7400 +31.69%

QualityStocks(MREO) $0.4944 +28.62%

BioMedWire(INBS) $17.9200 +25.23%

The QualityStocks Daily Stock List

Mereo BioPharma Group (MREO)

QualityStocks, StockMarketWatch, TradersPro, MarketBeat, MarketClub Analysis, BUYINS.NET, Real Pennies, Schaeffer's and InvestorsUnderground reported earlier on Mereo BioPharma Group (MREO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mereo BioPharma Group Plc (NASDAQ: MREO) (FRA: MAH0) is a clinical stage biopharmaceutical firm that is engaged in the acquisition, development and the commercialization of therapeutic treatments of various rare and oncological ailments, focusing on endocrine, respiratory and bone/musculoskeletal indications.

Mereo BioPharma Group has its headquarters in London, the United Kingdom and was founded in 2015. The firm serves consumers across the globe.

Mereo BioPharma Group Plc is part of the biotechnology research services industry and operates in the biotechnology industry in the healthcare sector.

Mereo BioPharma Group Plc’s product candidates include an aromatase inhibitor that was developed for the treatment of hypogonadotropic hypogonadism called BGS-649 or leflutrozole; a kinase inhibitor that recently concluded phase 2 clinical trials to treat severe exacerbations of chronic obstructive pulmonary disease called BCT-197 or acumapimod and an antibody immunoreceptor with ITIM and Ig domains called OMP-313M31 or etigilimab, which is currently undergoing phase 1b clinical trials for the treatment of tumors. The firm also develops OMP-305B83 or navicixizumab, which is currently in phase 1a clinical trials for the treatment of late line ovarian cancer as well as rare ailments product candidates such as MPH-966 or alvelestat, which is currently undergoing a phase 2 clinical trial evaluating its efficacy in treating Alpha-1 antitrypsin deficiency and BPS-804 or setrusumab, which is currently in phase 2b clinical trials for osteogenesis imperfecta treatment.

Mereo BioPharma Group (MREO), closed Friday's trading session at $0.4944, up 28.616%, on 45,551,345 volume with 00 trades. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.2/$3.39.

Eco Innovation Group (ECOX)

We reported earlier on Eco Innovation Group (ECOX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Eco Innovation Group Inc. (OTC: ECOX) is a consumer services firm that is engaged in developing innovative and impactful products and services.

The firm has its headquarters in Van Nuys, California and was incorporated in 1994. The firm serves consumers around the globe.

The company operates an incubator platform, which is used in paradigm shifts in research, sustainable product development and technology. Its objective is to help individuals and improve life on earth by nurturing and catalyzing the most impactful and innovative services and products and delivering those innovations to the world, which will in turn improve the quality of life in our communities and the world around us. The company generates the majority of its revenue from the sales of various products.

The enterprise is dedicated to developing and commercializing successful products and services. It develops power boosters for office and home applications that help decease electric bills, as well as other energy-saving related technologies. It also offers personal hair care and hair care products as well as cannabis products. In addition to this, the enterprise offers water treatment services that use technology and engineering solutions to provide safe and clean drinking water.

Eco Innovation Group (ECOX), closed Friday's trading session at $0.0005, up 25%, on 285,994,386 volume with 00 trades. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.000001/$0.0009.

Kutcho Copper (KCCFF)

We reported earlier on Kutcho Copper (KCCFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kutcho Copper Corp (OTCQX: KCCFF) (CVE: KC) (FRA: 1QV) is a resource development firm that is focused on acquiring and exploring resource properties in Canada.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1986, on August 29th. Prior to its name change in December 2017, the firm was known as Desert Star Resources Limited. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm primarily serves consumers in Canada.

The company is focused on expanding and developing copper-zinc projects. It explores, and develops copper, zinc, silver, gold, and other precious and base metal properties. The company holds a 100% interest in the Kutcho copper-zinc-gold-silver project, which comprises of one mining lease and 65 mineral exploration claims that cover an area of approximately 24,233 hectares located in northern British Columbia. The Kutcho property is located approximately 120km east of Dease Lake in northern British Columbia. The company intends to advance the Kutcho Project through permitting to a positive construction decision. It is currently engaged in discussions with Federal and Provincial governments regarding potential extensions of existing transmission lines towards its project.

Kutcho Copper (KCCFF), closed Friday's trading session at $0.1661, up 20.1881%, on 706,036 volume with 00 trades. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.071/$0.1807.

Doubleview Capital Corp. (DBLVF)

We reported earlier on Doubleview Capital Corp. (DBLVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Doubleview Capital Corp. is a mineral resource exploration and development company listed on the OTC Markets. The Company identifies, acquires and finances precious and base metal exploration projects in North America, particularly in the Province of British Columbia. It explores for copper, gold, silver, and zinc deposits. The Company’s projects include the Hat Deposit, Red Spring, and Mt. Milligan North. Incorporated in 2008, Doubleview Capital has its corporate headquarters in Vancouver, British Columbia.

The Company’s goal is to aggressively acquire and develop quality and highly prospective mineral projects in mining friendly parts of Canada and specifically in British Columbia. The Hat Gold Rich Porphyry Copper Project situated in Northwest British Columbia (Alkalic Porphyry Deposit type Model) was discovered in 2013/2014 by Doubleview Capital.

Red Spring is located in Northwest British Columbia. It features Copper, Gold, Silver and Zinc. The Mt Milligan North Property is located in Central British Columbia. It is an Alkalic Porphyry Deposit type Model.

Doubleview Capital previously announced the latest assay results from its Hat Gold-Copper Porphyry property positioned in northwestern British Columbia. Core samples from drill holes H026 and H031 extend the Lisle Zone mineralization to the south and at depth with strong gold and copper values and important silver, cobalt, and palladium.

Doubleview Capital Corp. (DBLVF), closed Friday's trading session at $0.9, up 16.1048%, on 304,744 volume with 00 trades. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.253/$0.9494.

Aehr Test Systems (AEHR)

Wall Street Resources, TradersPro, MarketClub Analysis, QualityStocks, StockEarnings, MarketBeat, Schaeffer's, StreetInsider, SmarTrend Newsletters, TraderPower, PennyToBuck, InvestorPlace, DrStockPick, FreeRealTime, CRWEWallStreet, CRWEPicks, Marketbeat.com, CRWEFinance, PennyOmega, StockHotTips, BestOtc, Promotion Stock Secrets, TipRanks, Street Insider, InsiderTrades, TopPennyStockMovers, The Street, Money Morning, StockOodles, StockMarketWatch, Wealth Insider Alert, Barchart, Zacks, Wall Street Mover, Trading Concepts, Top Pros' Top Picks, Early Bird, Chaikin PowerFeed, Financial Newsletter, PoliticsAndMyPortfolio, Investopedia, RedChip, The Wealth Report, Market Munchies, StocksEarning, 360 Wall Street, Stock Fortune Teller and Investing Futures reported earlier on Aehr Test Systems (AEHR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aehr Test Systems (NASDAQ: AEHR) (FRA: AYB) is a firm that is engaged in engineering, designing, manufacturing and selling burn-in and test equipment used in the semiconductor industry in Europe, Asia and the U.S.

The firm has its headquarters in Fremont, California and was incorporated in 1977. It operates in the technology sector, under the tech hardware and semiconductors industry, in the semi-conductors’ sub-industry.

The company sells and markets its products to test and burn-in service companies, electronics manufacturers, semiconductor contract assemblers and semiconductor manufacturers via a network of sales representatives and distributors. It provides test fixtures, test during burn-in systems, full wafer contact test systems and related accessories.

Its products include FOX systems, which include test and burn-in systems that have been designed to achieve contact with pads of a wafer at the same time; a DiePak carrier, which allows manufacturers of integrated circuits to carry out tests and burn-in of small or singulated bare multi-integrated circuit modules; the DiePak Loader, which carries out automatic loading of the DiePak carrier’s modules and the WaferPak Aligner, designed to carry out automatic alignment of the wafer to the WaferPak contractor. The enterprise also offers customer support and service programs, which include documentation services, customer training, applications engineering support, system repair and system installation.

Aehr Test Systems (AEHR), closed Friday's trading session at $26.32, up 15.9471%, on 3,387,143 volume with 00 trades. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $6.27/$34.3495.

AEON Biopharma (AEON)

Premium Stock Alerts, MarketClub Analysis, The Online Investor, QualityStocks and MarketBeat reported earlier on AEON Biopharma (AEON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AEON Biopharma Inc. (NYSE American: AEON) is a clinical-stage biopharmaceutical firm focused on the development of botulinum toxins.

The firm has its headquarters in Irvine, California. It operates as part of the biotechnology industry, under the healthcare sector. The company primarily serves consumers in the United States.

AEON Biopharma is party to license agreements with Viatris Inc. Its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, has been developed for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at episodic and chronic migraines, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The enterprise has completed enrollment and dosing of patients for a Phase II double blind study of ABP-450 for the treatment of both chronic and episodic migraine.

The company, which recently announced its latest financial results and entered into a definitive agreement with Daewoong Pharmaceutical Company Ltd, remains committed to seeking accelerated and full-label U.S. market entry for its ABP-450 formulation. AEON Biopharma’s success will not only extend its consumer reach but also open it up to new investment opportunities. This is in addition to generating additional value for its shareholders.

AEON Biopharma (AEON), closed Friday's trading session at $1.08, up -0.9174312%, on 87,568 volume with 00 trades. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.375/$16.056.

Coinbase Global Inc. (COIN)

CryptoCurrencyWire, BillionDollarClub, CurrencyNewsWire, Schaeffer's, QualityStocks, Zacks, MarketClub Analysis, InvestorPlace, MarketBeat, StockEarnings, The Street, Prfmonline, Early Bird, Greenbackers, Kiplinger Today, INO Market Report, Investopedia, SmallCapVoice, The Online Investor, OTCPicks, Ceocast News, Trading Tips, Eagle Financial Publications, InsiderTrades, FreeRealTime, The Wealth Report, HotOTC, CoolPennyStocks, Market Munchies, Daily Trade Alert, Top Pros' Top Picks, Chaikin PowerFeed, StockEgg, TradersPro, Trades Of The Day, StocksEarning, Jeff Bishop, Penny Invest, Stock Stars, Investors Underground, Stock Rich, BestOtc, Earnings360, Cabot Wealth, Pivot & Flow, Top Gun, CNBC Breaking News, The Stock Psycho, BullRally, Energy and Capital, TipRanks, AllPennyStocks, DividendStocks, StockReport, HotShotStocks, StockHotTips, Wealth Daily, Louis Navellier, FeedBlitz, Smartmoneytrading, Today's Financial News, The Night Owl, Summa Money, StockRich, bullseyeoptiontrading, MadPennyStocks, Profit Confidential, PennyTrader Publisher, PennyStockVille, PennyInvest, MarketClub Options, Stockpalooza, CRWEWallStreet, Atomic Trades, Dynamic Wealth Report, AlphaShark Trading, Dawn Report, BloomMoney, Blaque Capital Stocks, Stock Analyzer, wyatt research newsletter, WiseAlerts, wealthmintrplus, Wealth Whisperer, TradingPub, Trading with Larry Benedict, TradeSmith Daily, StockMister, Penny Stock Finder, Stock Fortune Teller, Early Investing, Standout Stocks, Round Up the Bulls, Premium Stock Alerts, Pennybuster, Penny Stock Rumble, Momentum Traders, MicrocapVoice, InvestorsUnderground, Green Chip Stocks and Stock Traders Chat reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crypto has come a long way from being seen as risky and uncertain. As 2026 begins, digital assets are no longer sitting on the edges of finance; they are becoming part of the global financial system. Clearer rules, growing trust from big institutions, and new technology are shaping how crypto works and who uses it. For investors, understanding the key trends ahead matters more than chasing hype.

One major trend to watch is the continued rise of institutional investors. In the past, crypto was driven mostly by individual traders. That is changing fast. Large institutions such as pension funds, asset managers, and banks are now entering the space through crypto ETFs and similar products. These tools make it easier and safer for traditional investors to gain exposure to digital assets. As more big players join in, crypto prices are likely to move more in line with global economic trends, such as interest rates and inflation, rather than social media excitement.

Another important trend is the growth of tokenization. Tokenization means turning real-world assets like stocks, bonds, or real estate into digital versions that live on blockchains. While this is still at an early stage, momentum is building. Regulators are becoming more open to the idea, and financial institutions are testing ways to use blockchain systems for faster and cheaper transactions. In the long run, tokenization could change how assets are traded, owned, and settled across markets.

Stablecoins are also becoming a key part of crypto’s future. These digital currencies, which are usually tied to the value of the U.S. dollar, grew rapidly in 2025. More companies are issuing them, and more people are using them for payments and transfers. The big focus in 2026 will be building strong systems that reduce risk and allow smooth movement of money between platforms. Clear rules and shared standards will be necessary for stablecoins to work reliably at a global scale.

Crypto is also expanding the idea of what can be traded. Blockchain-based markets operate all day, every day, without borders. This has led to growth in products like perpetual futures and prediction markets. These tools are no longer limited to crypto prices alone. Investors are now using them to trade commodities, interest rates, and other financial indicators, blending crypto with traditional finance in new ways.

Finally, the connection between crypto and artificial intelligence is getting stronger. As AI systems become more independent, they will need ways to pay each other and complete tasks automatically. Blockchains offer a low-cost and efficient solution for this. This could lead to a new machine-driven economy where crypto supports billions of small transactions behind the scenes.

Together, these trends show that crypto in 2026 is becoming more mature, more useful, and more connected to everyday finance. As this maturity spreads out, major crypto industry players like Coinbase Global Inc. (NASDAQ: COIN) could have a much bigger addressable market to serve.

Coinbase Global Inc. (COIN), closed Friday's trading session at $240.78, up -1.9585%, on 8,104,541 volume with 00 trades. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $142.58/$444.645.

American Bitcoin Corp. (ABTC)

QualityStocks, InsiderTrades and Schaeffer's reported earlier on American Bitcoin Corp. (ABTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Changpeng Zhao (CZ), the founder of Binance, recently reignited discussion about the future of crypto by arguing that the sector remains relatively small despite its long-term promise. His remarks, shared widely after being reposted by Watcher.Guru, quickly circulated across social media platforms and crypto forums, prompting renewed debate about where the industry stands in its development cycle.

Zhao described the current phase of crypto as an early chapter. In his view, blockchain-based systems have yet to achieve widespread adoption across key areas such as payments, financial services, public administration, and digital property rights. For many investors, this interpretation supports the idea that present valuations represent early entry opportunities rather than the peak of a market cycle, fueling optimism about long-term prospects.

As of Jan. 4, the total value of the global crypto market was estimated at $3.17 trillion. While that figure may appear large in isolation, it accounts for less than 3% of the estimated $110 trillion global equity market. Traditional asset classes such as equities, fixed income instruments, and property continue to dominate capital allocation worldwide. Zhao’s comparison underscores how limited crypto’s footprint remains when viewed alongside established financial markets.

Zhao stepped down as Binance’s chief executive in 2023 following a settlement between the exchange and U.S. regulators. Despite his departure from the role, he continues to shape discussions within the industry.

With a following that exceeds nine million people, his statements often resonate with both individual traders and institutional participants. His credibility is closely tied to his role in building Binance into the world’s largest digital asset exchange by trading volume.

Online reactions to Zhao’s statement were largely favorable. Many users echoed the view that blockchain adoption has not yet approached its technical or economic limits. Commentators described the current market environment as one focused on accumulation rather than saturation, aligning with a cautiously optimistic mood seen across parts of the crypto space in early 2026.

Despite more than a decade of development, cryptocurrency usage still represents a small fraction of global financial activity. Most transactions worldwide rely on established banking and payment networks, while blockchain-based alternatives remain largely outside everyday commercial and governmental operations. This gap is often cited as evidence that significant room for expansion remains.

Institutional participation has grown through products such as exchange-traded funds, custodial solutions, and on-chain financial tools. Even so, these holdings typically make up a limited share of traditional portfolios. Broader regulatory consistency and improved infrastructure could encourage deeper institutional involvement over time.

At the same time, the sector continues to face challenges. Price volatility, speculative behavior, and security risks remain defining features. Adoption has followed an uneven path, marked by rapid advances followed by pullbacks.

While risks persist, supporters believe the broader trajectory points toward continued innovation, gradual integration, and a larger role within the global economy over time.

The discussions about the untapped potential of crypto give companies like American Bitcoin Corp. (NASDAQ: ABTC) added impetus to double down on their strategies to prepare to tap the opportunities that are likely to emerge as digital assets get more traction in the mainstream financial world.

American Bitcoin Corp. (ABTC), closed Friday's trading session at $1.83, up -4.1885%, on 11,500,981 volume with 00 trades. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.6275/$14.65.

Vision Marine Technologies Inc. (VMAR)

QualityStocks, MissionIR, SmallCapRelations, SeriousTraders, Green Energy Stocks, Tiny Gems, Stocks to Buy Now, Tip.us, StocksToBuyNow, TinyGems, TechMediaWire, InvestorBrandNetwork, SmallCapSociety, NetworkNewsWire, RedChip, Premium Stock Alerts, StockEarnings, 360 Wall Street, Market Munchies, Early Bird, MarketBeat, Jeff Bishop, InvestorPlace, StocksEarning, StreetInsider and Green Chip Stocks reported earlier on Vision Marine Technologies Inc. (VMAR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Five European cities are shining in sustainability efforts, demonstrating how urban centers can leverage technology and innovation to create more livable, environmentally responsible environments. From revolutionary transport systems to circular economies, these municipalities are proving that smart city solutions can balance growth with environmental protection while enhancing residents’ quality of life.

Vienna: The Austrian capital exemplifies how resident wellbeing and urban advancement can progress together without compromise. Through TINA Vienna, the city has come up with intelligent strategies to support electric mobility, installing 440 charging locations while targeting renewable resources to meet half its energy requirements. Neighborhood redevelopment in heavily populated areas is also showing how sustainable practices, planning and technology can merge to create more efficient environments that serve all residents equally.

Paris: The French capital is pursuing an ambitious transformation centered on the “15-minute city” model that brings essential services closer to residents, fundamentally reshaping how Parisians navigate daily life. Home to more than 20,000 bicycles as well as 1,800 scooters that are shared, the city encourages sustainable transport as a way to tackle one of Europe’s most complex mobility challenges. Grand Paris Express, the continent’s biggest urban mobility undertaking, represents a key element of this transformation. Webuild takes part by delivering strategically critical infrastructure to reshape the metropolitan region via new automated queues and faster connections throughout the region.

London: Britain’s capital stands among Europe’s most innovative cities, successfully converting abandoned areas into green, inclusive neighborhoods while investing in cutting-edge digital technologies. Smarter London Together, the city’s strategic plan, pursues more efficient services, smart connectivity, data management, and public-private collaboration across the metropolis. Emphasis on electric mobility, renewable resources, and AI-based solutions reinforces London’s position as a global innovation hub, proving sustainability and economic growth can advance together successfully.

Amsterdam: The Dutch capital serves as a European model where circular economy principles and sustainable mobility guide every urban decision. With more than 850,000 bicycles citywide and progressive bans on fossil-fuel vehicles, Amsterdam has transformed its traffic into an efficient system prioritizing bikes and pedestrians over cars. Amsterdam Smart City, a public-private partnership, functions as a testing ground for digital solutions and sustainable energy initiatives. The Circular strategy targets waste reduction and aims to create a fully circular economy by 2050, enhancing life quality for residents and visitors alike.

Copenhagen: The Danish capital has emerged as one of Europe’s most advanced smart cities, with the Cityringen metro line exemplifying this evolution perfectly. Developed by Webuild, the system has revolutionized urban mobility by offering connections that are sustainable, faster, and more frequent throughout the city. Its 17 stations in the urban core have reduced traffic congestion at street level and improved daily quality of life, making it easier for residents to navigate without depending on cars.

These five cities demonstrate how European urban centers are leveraging technology, infrastructure investment, and forward-thinking policies to create more sustainable, livable environments while addressing pressing climate challenges and setting examples for cities worldwide to follow and adapt.

As more cities focus on sustainability in their policies, a lot more companies like Vision Marine Technologies Inc. (NASDAQ: VMAR) will inevitably sprout to address the emerging market needs.

Vision Marine Technologies Inc. (VMAR), closed Friday's trading session at $0.1952, up 0.7743934%, on 3,513,402 volume with 00 trades. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.1593/$25.5.

Calidi Biotherapeutics Inc. (CLDI)

QualityStocks, InvestorBrandNetwork, MissionIR, SeriousTraders, SmallCapRelations, BioMedWire, SmallCapSociety, Tip.Us, StocksToBuyNow, NetworkNewsWire, TinyGems, Stocks to Buy Now, Tiny Gems, MarketClub Analysis, MarketBeat, Premium Stock Alerts and InsiderTrades reported earlier on Calidi Biotherapeutics Inc. (CLDI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Immunotherapy has emerged as a more gentle way to treat cancer over the past few years. However, it is very expensive and results are usually inconsistent among patients, especially those suffering from solid tumors. Researchers in Hong Kong have come up with a biomaterial containing silica that can help to address the current shortcomings of immunotherapy and dramatically improve efficacy rates. 

Prof. Yung Kin-lam, who led the team of researchers, explains that the nanomaterial they developed is biocompatible, non-toxic, natural and comes in the shape of a nanomatrix. This biomaterial accelerates the maturation of dendritic cells (DCs) outside the body of the patient and these are infused into the patient to wake up the body’s ability to identify, attack and kill cancer cells. These ‘nanozigzag’ particles also prime the immune system to such an extent that tumor cells can no longer ‘camouflage’ themselves and evade being attacked. 

Preclinical tests of this innovative biomaterial revealed in the study have shown that they are effective at inhibiting the growth of tumors, prolonging the memory of the immune system in identifying malignant cells, and prolonging the duration within which the immune system has a boosted ability to respond to and attack tumors. 

Another key feature of this innovative treatment is that since it is made outside the patient’s body, it can work even for patients whose immunity has been suppressed or compromised by other treatments like chemotherapy. The production process is standardized and scalable, which gives it the added benefit of cost-reduction and expedited production cycles. 

This approach opens the door to the future production of DC vaccines with a more universal applicability. The team plans to test how their approach can be used in treating other immune-system-linked conditions like multiple sclerosis and systemic lupus. Their success in treating these other conditions would prove that the approach has an even wider scope of diseases where it can be applied. 

For now, the team is focused on working with other medical facilities in Mainland China and Hong Kong to optimize the protocols they use to develop the cell cultures, conduct further evaluation of the efficacy of the therapy, and lay the foundation for the treatment to be taken through clinical trials before it is eventually available to patients once it passes all the steps required to obtain regulatory approval. 

There is plenty of hope in the future of immunotherapy because so many companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) and university-based research teams are exploring different avenues through which immunotherapy can not only become effective for all cancer patients but can also be produced cost-effectively to make the therapy affordable for as many patients as possible. 

Calidi Biotherapeutics Inc. (CLDI), closed Friday's trading session at $1.15, up -0.862069%, on 36,412 volume with 00 trades. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $1.1/$19.2.

Rivian Automotive Inc. (RIVN)

BillionDollarClub, Green Car Stocks, Schaeffer's, QualityStocks, InvestorPlace, MarketClub Analysis, MarketBeat, Early Bird, The Street, Kiplinger Today, StockEarnings, Financial Newsletter, INO Market Report, Investopedia, The Online Investor, Zacks, GreenCarStocks, FreeRealTime, AllPennyStocks, Daily Trade Alert, TipRanks, The Night Owl, Market Munchies, InsiderTrades, StocksEarning, Trades Of The Day, Louis Navellier, Cabot Wealth, DividendStocks, StockReport, InvestorIntel, InvestorsUnderground, Chaikin PowerFeed, Top Pros' Top Picks, Premium Stock Alerts, 360 Wall Street, Pivot & Flow, Jeff Bishop, Prince Report, Rick Saddler, Top Pros’ Top Picks, Hit and Run Candle Sticks, Investors Underground, bullseyeoptiontrading, TradersPro, Premium Stock Picks and Earnings360 reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dutch engineering students have unveiled an electric vehicle concept designed around a simple idea: drivers should be able to fix their own cars. Developed by Eindhoven University of Technology’s TU/ecomotive team, the prototype challenges an industry model that typically locks repairs behind dealerships, proprietary tools, and tightly controlled service networks. The vehicle even carries its own toolbox, signaling a deliberate shift toward user-controlled maintenance. 

The project arrives as debates over repair access continue to grow across Europe. While recent EU consumer rules have expanded repair rights for items like smartphones and household electronics, passenger vehicles remain largely outside those protections. 

The students behind the concept see their work as both a technical experiment and a policy signal, offering lawmakers and manufacturers a tangible example of how cars could be designed from the outset with repairability in mind. 

Known as ARIA, short for Anyone Repairs It Anywhere, the vehicle rethinks how electric cars are assembled. Instead of tightly integrated systems that require specialized equipment, the design relies on standardized, removable components. This approach reduces reliance on brand-specific service channels and opens the door for owners to handle routine fixes themselves. 

A central feature of the EV prototype is the battery system. Rather than a single, heavy unit embedded into the chassis, ARIA uses six smaller battery modules, each light enough to be removed by hand. The exterior panels follow the same philosophy. Quick-release body sections allow fast access to internal components and can be swapped out entirely if damaged, avoiding costly shop visits for minor issues. 

Software plays a supporting role, with a companion diagnostics app providing real-time information about the car’s condition, while a printed manual guides users through common maintenance tasks. According to the team, everything needed for basic repairs is stored inside the vehicle, eliminating the need for external tools or specialized training. The car’s appearance generally reflects its functional priorities as well. 

A compact body, upward-opening scissor doors, and a stripped-back interior keep weight down while giving the prototype a distinctive look. TU/ecomotive says the vehicle weighs about 1,400 pounds and is designed for a working range of roughly 220 km, positioning it as a practical urban or commercial solution rather than a luxury product. 

Collaboration played a key role in the prototype’s development. Students from Fontys University of Applied Sciences and vocational education provider Summa contributed alongside the TU/ecomotive team, combining academic research with hands-on technical skills. Team leader Taco Olmer said the project is meant to challenge assumptions about what is feasible in modern car design. 

By delivering a working prototype within a year, the students aim to show that repair-friendly and sustainable vehicles are not a distant ideal, but a realistic option the wider industry could pursue. Over the past decade, TU/ecomotive has built 10 experimental vehicles, each intended to question conventional approaches to mobility and point toward alternative paths forward. 

It would be interesting to hear what luxury EV makers like Rivian Automotive Inc. (NASDAQ: RIVN) think about this concept car and what its chances of commercial success are in markets like the U.S. where the population’s love for larger vehicles makes them the obvious choice for manufacturers. 

Rivian Automotive Inc. (RIVN), closed Friday's trading session at $19.22, up -3.3685%, on 32,467,371 volume with 00 trades. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $10.36/$22.69.

Cresco Labs Inc. (CRLBF)

CannabisNewsWire, QualityStocks, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New York regulators have published a series of year-end reports outlining how the state’s legal cannabis industry has developed, highlighting strong sales, growing tax revenue, progress on equity goals, and expanded access for medical patients. 

According to the reports, total legal marijuana sales in the state have now passed $2.5 billion since recreational use was approved. Of that amount, roughly $1.6 billion came in during the most recent year, through November. The number of licensed retail outlets has also grown from 261 stores in 2024 to 556 by 2025, nearly doubling in just one year. 

The Office of Cannabis Management noted that New York continues to surpass its social equity targets. About 55% of recreational cannabis licenses are held by social and economic equity entities. Within that group, 50% are owned by people from minority communities, and 47% are run by women. 

State officials also detailed enforcement efforts aimed at limiting illegal cannabis sales. In 2025, regulators carried out more than 2,000 enforcement actions, seizing more than $20 million worth of unlicensed marijuana products. 

The reports also note changes to the state’s medical marijuana program signed into law by Governor Kathy Hochul. The updates expand access by simplifying patient certification, allowing reciprocity for visitors from other states, and permitting adults aged 18 and older to grow marijuana plants for therapeutic purposes. Officials said the changes are intended to modernize the program and better serve patients across New York. 

Tax revenue remains a major outcome of legalization. From April 2023 through the end of November 2025, the state collected approximately $341 million in cannabis-related taxes from recreational and medical sales. However, officials acknowledged that sales are concentrated among a relatively small group of retailers. As of late November, the top 10 cannabis stores accounted for nearly 30% of all sales, while the top 50% of operating locations generated about 80% of total revenue. 

The data also suggest that legalization has not led to increased youth use. Surveys show that the share of adolescents reporting recent marijuana use declined from 20% in 2013 to 12.5% in 2023. 

Regulators also announced an extension for conditional recreational cannabis licenses, pushing the renewal deadline to the end of the year. The move is intended to give license holders more time to secure compliant locations, particularly amid zoning concerns affecting more than 100 businesses located near schools or religious institutions. 

Separately, lawmakers passed a measure that would give marijuana distributors and manufacturers additional time to file quarterly tax returns. If approved, the filing window would expand from 20 days to 50 days after each reporting period ends. 

This positive information coming after the hiccups that threatened to derail the program in its initial stages after the launch of legal sales comes as a welcome relief to industry players like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) that are happy to see new markets succeed at giving adults access to products from licensed outlets in states with enabling regulations. 

Cresco Labs Inc. (CRLBF), closed Friday's trading session at $1.24, up -3.125%, on 301,351 volume with 00 trades. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.4256/$2.3.

The QualityStocks Company Corner

Safe Pro Group Inc. (NASDAQ: SPAI)

The QualityStocks Daily Newsletter would like to spotlight Safe Pro Group Inc. (NASDAQ: SPAI).

SPAI Ventures is a wholly owned subsidiary of Safe Pro Group Inc., that was established to pursue both strategic collaborations and investments with Ukrainian and other international tech developers.

The company plans to create a collaborative framework to accelerate growth in defense tech, fostering innovation, and creating optimal conditions for technological advancement.

Through SPAI Ventures, Safe Pro Group Inc. will evaluate opportunities in which to invest or to commercialize technologies that it believes could complement the capabilities of its portfolio of AI and ballistic protective solutions.

Safe Pro Group Inc. (NASDAQ: SPAI) , a developer of AI-powered security and defense solutions, recently announced the formation of a wholly-owned subsidiary called SPAI Ventures ( https://ibn.fm/DYrQK ). This unit was established to evaluate and pursue strategic partnerships and investments with technology developers from the Ukraine and other international markets.

Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (AI), machine learning (ML), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (UXO), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI™ can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (UXO). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI™ rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (AWS) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (sUAS) (drones). It serves enterprises in utilities & telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (DFR) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (EOD) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM®) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

Investment Considerations
  • Unique, battle-tested and patented AI image analysis technology ready for commercialization in U.S. defense and public safety markets following more than 2 years of real-world usage in Ukraine.
  • Well positioned to capitalize on U.S. military’s increased strategic focus on domestically produced drone and AI technologies through integration with currently deployed platforms such as the U.S. Army’s Tactical Assault Kit (TAK) ecosystem for military force protection.
  • The patented SpotlightAI™ platform enables real-time detection of over 150 types of mines and UXO using AI and drone imagery and is now operating at scale, creating the world’s largest datasets of real-world landmines and UXO built on more than 1.6 million battlefield images processed and 28,000 threats identified.
  • Safe Pro is addressing a global, multi-billion-dollar need for scalable defense, public safety and demining solutions.

Safe Pro Group Inc. (NASDAQ: SPAI), closed Friday's trading session at $5.7, up 2.1505%, on 391,528 volume with 00 trades. The average volume for the last 3 months is 427,265 and the stock's 52-week low/high is $1.47/$9.1599.

Recent News

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ)

The QualityStocks Daily Newsletter would like to spotlight Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ).

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Trilogy Metals' JV company Ambler Metals has recently approved the $35 million 2026 program focused on initiating mine permitting for the Arctic Project while advancing technical de-risking work

The joint venture plans to target mine permit submissions in 2026, potentially leveraging FAST-41 federal expedited permitting for critical infrastructure projects

Trilogy maintains a strong cash position exceeding $50 million, with additional funding expected from a $35.6 million US Department of War investment anticipated to close in early 2026

In an industry with a historically lengthy gap between discovery and production, the ability to advance projects through the permitting gauntlet separates aspirational deposits from future mines. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is positioning 2026 as the year that transforms the Arctic Project in Alaska from a world-class copper resource into a permitted mining operation.

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) is a North American mineral exploration and development company focused on advancing high-grade copper and critical mineral assets in Alaska. The company operates through Ambler Metals LLC, a 50/50 joint venture with South32 Ltd., and is progressing one of the world’s most prospective undeveloped polymetallic districts.

Trilogy is uniquely positioned with exposure to copper, zinc, lead, cobalt, silver, and gold—commodities vital to global electrification and energy transition. Its vision is to responsibly develop the Ambler Mining District into a premier domestic source of critical minerals while delivering long-term value to shareholders and local communities.

The company is guided by values of trust, respect, integrity, and partnership, and works closely with Alaska Native stakeholders to advance its strategy in a sustainable and inclusive manner.

Projects

Arctic Project

The Arctic project is Trilogy’s flagship asset and one of the highest-grade known copper deposits in the world, with an average grade of approximately 5% copper equivalent. Located roughly 470 kilometers northwest of Fairbanks, Alaska, Arctic is a volcanogenic massive sulphide (VMS) deposit hosting copper, zinc, lead, gold, and silver. The project is at the feasibility stage and is currently undergoing permitting activities.

According to the 2023 Feasibility Study, Arctic will support a 10,000 tonne-per-day open-pit mining operation over a 13-year mine life. Based on long-term metal prices of $3.65/lb copper, $1.15/lb zinc, $1.00/lb lead, $1,650/oz gold, and $21.00/oz silver, the project demonstrates a pre-tax NPV8% of $1.5 billion and an IRR of 25.8%. After-tax, the NPV8% is $1.1 billion with a 22.8% IRR. At April 2025 spot metal prices, the after-tax NPV8% increases to $1.9 billion with a 31.1% IRR.

The project’s metallurgy supports high recoveries: 92.1% for copper, 88.5% for zinc, and 61.3% for lead. Life-of-mine payable production is projected to total 1.9 billion pounds of copper, 2.2 billion pounds of zinc, 335 million pounds of lead, 423,000 ounces of gold, and 36 million ounces of silver. Cash costs are expected to average $0.72 per pound of payable copper, with all-in costs estimated at $1.61 per pound.

Bornite Project

Located approximately 25 kilometers southwest of Arctic, the Bornite project is a large-scale carbonate replacement copper deposit with significant upside. According to the 2025 Preliminary Economic Assessment (PEA), Bornite is expected to support a 6,000 tonne-per-day underground operation over a 17-year mine life, using re-purposed infrastructure from the Arctic Project.

Bornite contains an estimated 6.5 billion pounds of inferred copper. The PEA outlines pre-tax NPV8% of $552.1 million and IRR of 23.6%, with an after-tax NPV8% of $393.9 million and IRR of 20.0%, based on a copper price of $4.20/lb. Total payable copper production over the life of mine is projected at 1.9 billion pounds.

Bornite’s mineralization occurs in stacked, stratabound zones rich in chalcopyrite, bornite, and chalcocite. A subset of the South Reef zone offers high-grade underground mining potential, further enhancing Bornite’s future optionality.

Exploration Pipeline

The Upper Kobuk Mineral Projects span 471,796 acres and include more than 30 additional mineralized prospects beyond Arctic and Bornite. These lie along two geologically distinct and highly mineralized belts: the Ambler Schist Belt and the Bornite Carbonate Sequence.

The Ambler Schist Belt features multiple VMS-style prospects along its 100-kilometer strike length, including Sunshine, Snow, Nora, Shungnak, and BT. Neighboring deposits like Smucker (Teck) and Sun (Valhalla Metals) affirm the district’s regional potential. Ten of Trilogy’s VMS prospects have been drill tested with encouraging results.

Meanwhile, the Bornite Carbonate Sequence extends 16 kilometers along the Cosmos Hills and hosts additional targets such as Pardner Hill and Aurora Mountain. These zones show strong signs of copper and cobalt mineralization and were partially tested during the Kennecott era, suggesting significant room for expansion.

Together, these assets form the foundation of a multi-decade development and discovery platform in one of the most prospective undeveloped mining districts in North America.

Market Opportunity

Trilogy Metals is poised to benefit from long-term structural demand for copper and other critical minerals essential to electrification, energy infrastructure, and clean technologies. Copper, in particular, is expected to see major supply shortfalls due to underinvestment and accelerating demand from power grids, EVs, and data centers.

According to a Grand View Research report, the global copper market is projected to grow from $241.88 billion in 2024 to $339.95 billion by 2030, at a CAGR of 6.5%, driven by the energy transition and rising infrastructure investments.

Trilogy’s Arctic and Bornite projects are strategically located in Alaska, a top-tier mining jurisdiction with strong permitting frameworks and growing federal and state-level support, including recent executive orders streamlining approvals for the Ambler Access Project. The company also maintains a $50 million shelf prospectus and an active $25 million ATM equity program to fund future development.

Leadership Team

Tony Giardini, President and Chief Executive Officer, leads Trilogy Metals with extensive executive experience in the mining industry. He previously served as President of Ivanhoe Mines Ltd., and as Executive Vice President and Chief Financial Officer at Kinross Gold Corporation. Earlier in his career, he held senior roles at Placer Dome Inc. and KPMG. Mr. Giardini is both a Chartered Professional Accountant and a Certified Public Accountant.

Elaine M. Sanders, Chief Financial Officer and Corporate Secretary, brings over 25 years of financial and accounting experience to Trilogy. She is responsible for the company’s financial reporting, compliance, and governance functions. Ms. Sanders has overseen multiple financings and exchange listings throughout her career. She holds a Bachelor of Commerce from the University of Alberta and is both a Chartered Professional Accountant and Certified Public Accountant.

Richard Gosse, Vice President, Exploration, is a veteran geologist with 35 years of global exploration experience. He previously led exploration initiatives at Dundee Precious Metals and Ivanhoe Mines Ltd., where he oversaw the discovery efforts at the renowned Oyu Tolgoi copper-gold project in Mongolia. Mr. Gosse holds a B.Sc. in Geology from Queen’s University and an M.Sc. in Mineral Exploration from Imperial College London.

Investment Considerations
  • Trilogy Metals holds a 50% interest in the UKMP, a 471,796-acre (190,929-hectare) land package hosting two high-grade undeveloped copper deposits.
  • The Arctic Project delivers robust feasibility-stage economics with an after-tax NPV of $1.1 billion and grades exceeding 4% copper equivalent.
  • The adjacent Bornite Project contains 6.5 billion pounds of inferred copper and can extend the district’s mine life to over 30 years.
  • Trilogy benefits from strategic partnerships with South32, NANA Regional Corporation, and the State of Alaska, bolstering its financial strength and permitting outlook.
  • The company operates in a top-tier jurisdiction for mining investment and is led by a seasoned executive team with decades of industry experience.

Trilogy Metals Inc. (NYSE American: TMQ), closed Friday's trading session at $5.17, up 1.5717%, on 3,009,989 volume with 00 trades. The average volume for the last 3 months is 3,474,890 and the stock's 52-week low/high is $1.06/$11.29.

Recent News

OptimumBank Holdings Inc. (NYSE American: OPHC)

The QualityStocks Daily Newsletter would like to spotlight OptimumBank Holdings Inc. (NYSE American: OPHC).

OptimumBank Holdings (NYSE American: OPHC) announced the launch of a limited-time owner-occupied commercial real estate financing promotion for the first quarter of 2026, offering qualified borrowers up to 80 percent loan-to-value at an interest rate of SOFR plus 2.67 percent with a one-quarter point origination fee. The promotion is aimed at supporting growing businesses seeking competitive financing solutions while reinforcing the bank's relationship-driven lending model and local decision-making approach, with applications required to be completed and submitted by March 31, 2026.

To view the full press release, visit https://ibn.fm/dRGV8

OptimumBank Holdings Inc. (NYSE American: OPHC) is a single bank holding company that owns 100% of OptimumBank, a community bank headquartered in Fort Lauderdale, Florida. OptimumBank offers relationship-driven banking available in person, by phone, and online, serving both local and international clients by offering an alternative to the high fees and impersonal service of larger institutions. Its expertise in real estate and commercial lending has made it a preferred partner for borrowers seeking knowledgeable, accessible financial support.

Driven by disciplined execution and a commitment to local relationships, OptimumBank has experienced substantial organic growth, positioning itself as one of the fastest-growing community banks in the region. The company has surpassed $1 billion in total assets and remains focused on scaling efficiently, maintaining sound credit quality, and delivering strong returns for shareholders.

Looking ahead, the bank is embracing technology modernization while remaining grounded in the principles of relationship-based banking. A new open-architecture core platform, targeted loan expansion, and sustained deposit growth are key pillars of its forward strategy.

Products

OptimumBank offers a full suite of business and personal banking solutions, including Business Banking, Business Lending, SBA Lending Solutions, Treasury Management, and Personal Banking. Its lending focus includes commercial real estate, multifamily, construction, residential, and consumer loans.

The bank achieved Preferred Lender status with the Small Business Administration in just over two years—an uncommon accomplishment—and rapidly scaled its SBA lending operations from zero in record time. Its treasury services and deposit products are supported by a stable core funding base, with a growing percentage of noninterest-bearing demand deposits.

In late 2025, OptimumBank is rolling out a next-generation core banking platform with API-based architecture, enabling paperless processing, streamlined onboarding, and enhanced treasury management tools.

OptimumBank is deeply engaged in the community, providing support to organizations such as Habitat for Humanity of Broward, along with schools, synagogues, and many other nonprofits that are important to its customers and neighbors.

Market Opportunity

The U.S. community banking sector represents a multi-trillion-dollar opportunity, especially in underserved regions where local institutions continue to consolidate. South Florida’s real estate market and growing population create robust demand for personalized commercial lending, construction loans, and deposit services.

According to Mordor Intelligence, the U.S. commercial banking market is expected to grow from $732.5 billion in 2025 to $915.45 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.56%. Within this landscape, OptimumBank is well-positioned to benefit from regional consolidation and rising customer dissatisfaction with national banks.

OptimumBank’s continued investments in talent, technology, and compliance infrastructure ensure scalability as it targets its next major milestone: becoming a top 200 publicly traded bank in the United States. The bank has maintained a track record of net recoveries in recent years, with no loan losses in over seven years and no defaults in its current loan portfolio. In addition, OptimumBank has near-zero exposure to long-dated, low-yield bonds, avoiding the balance sheet drag that has pressured many regional peers.

Leadership Team

Moishe Gubin, Chairman of OptimumBank Holdings, has been a director since 2010. He is also the CEO of Strawberry Fields REIT and previously served as CFO of Infinity Healthcare Management. Gubin is a licensed CPA in New York and the founder of the Midwest Torah Center.

Timothy Terry, President and CEO, has led OptimumBank since 2013 and has over 35 years of banking experience. He previously held senior roles at Enterprise Bank of Florida and other financial institutions, with a background in lending, branch administration, and sales.

Elliot Nunez, EVP and CFO, joined the bank in 2020. He previously served as CFO for Brickell Bank and Mellon United National Bank and worked at KPMG. Nunez is a licensed CPA and Chartered Global Management Accountant.

Investment Considerations
  • OptimumBank has delivered record earnings and profitability, with 2024 net income of $13.1 million and Core ROAE above 23 percent, all achieved without credit losses for the past seven years.
  • The company expects to surpass $1.2 billion in assets by the end of 2025 and projects continued growth to $1.5 to $1.6 billion by year-end 2026, supported by a clean balance sheet and no exposure to long-dated, low-yield bonds.
  • OptimumBank achieved SBA Preferred Lender status in just over two years and grew its SBA lending program from zero, demonstrating rapid execution and small business demand.
  • Strategic investments in a new digital core platform are expected to enhance scalability and user experience.
  • OptimumBank maintains a strong capital position and disciplined underwriting, with Tier 1 capital well above regulatory minimums and significant institutional ownership, including a notable position held by Alliance Bernstein.
  • OPHC trades at a significant discount relative to peers, despite stronger growth, credit quality, and returns, creating an attractive entry point for investors.

OptimumBank Holdings Inc. (NYSE American: OPHC), closed Friday's trading session at $4.36, up 0.6928406%, on 26,724 volume with 00 trades. The average volume for the last 3 months is 32,107 and the stock's 52-week low/high is $3.53/$4.85.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT).

HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by Lauren Dubinsky that outlined FDA clearances and approvals across the medical device sector.  HeartBeam's 12-lead electrocardiogram synthesis software was cleared Dec. 8 to assess arrhythmias by converting heart signal data captured from 3 dimensions using the company's portable, non-invasive recorder into a standard 12-lead ECG format suitable for remote clinical review. HeartBeam recently reinforced its technology leadership with recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide and trailing only GE Healthcare, in 12-lead ECG innovation among 243 companies evaluated in PatentVest's "Total Cardiac Intelligence" report, according to an InvestorBrandNetwork report. The ranking r eflects the strength of its intellectual-property foundation, with 82 global patent publications across 15 patent families supporting its three-dimensional cardiac signal capture and 12-lead ECG synthesis architecture, underscoring the company's growing influence in next-generation remote cardiac monitoring.

To learn more about Heartbeam's Portable ECG Technology, visit https://ibn.fm/pfPB1

HeartBeam Inc. (NASDAQ: BEAT) is a medical technology company pioneering a new approach to cardiac care by delivering hospital-grade electrocardiogram (ECG) insights outside traditional clinical settings. Its proprietary platform supports a scalable app-based solution for real-time heart monitoring.

The company’s mission is to empower both patients and physicians with actionable cardiac data wherever symptoms begin, addressing a critical gap in the first hours of cardiac events. Through its connected cardiac care ecosystem, HeartBeam is establishing a new model for remote monitoring that deepens patient engagement and delivers more actionable insights for physicians. This approach is designed to obtain early diagnosis which could reduce time to treatment, improve outcomes, and lower costs across the healthcare continuum.

HeartBeam’s system aims to bring clinical-grade cardiac assessment into the home. HeartBeam is preparing for commercial launch as its 12-lead ECG synthesis software undergoes regulatory review, building on prior clearance of its 3D ECG system for arrhythmia assessment. The company plans to leverage its unique longitudinal ECG dataset and deep learning algorithms to advance predictive capabilities in the future.

HeartBeam is headquartered in Santa Clara, California.

Products

HeartBeam’s flagship innovation is its credit card-sized, cable-free ECG device that collects heart signals in three non-coplanar dimensions and synthesizes a 12-lead ECG. Cleared by the FDA in December 2024 for arrhythmia assessment, the HeartBeam System enables patients to capture high-fidelity heart data during symptomatic episodes, even outside a clinical environment.

The company’s pending 12-lead ECG synthesis software, developed from the same 3D signal acquisition, successfully met clinical endpoints in the VALID-ECG study and is currently under FDA review for arrhythmia assessment. This software combined with an on-demand cardiologist reader service is expected to form the backbone of HeartBeam’s commercial launch strategy, providing patients with access to a synthesized 12-lead ECG outside of the traditional hospital setting and enabling physician interpretation of patient ECGs from anywhere.

From the core, the team is building an ecosystem that includes integration with wearables, automated arrhythmia assessments, AI-driven wellness features, community features and trending insights. The ecosystem is intended to drive adoption and increase the overall value of the HeartBeam System.

Artificial Intelligence and Predictive Analytics

To enhance its diagnostic capabilities, HeartBeam is developing AI-powered arrhythmia detection algorithms to be validated in collaboration with Mount Sinai Heart. In early testing, these deep learning algorithms achieved diagnostic accuracy comparable to standard 12-lead ECGs when classifying atrial fibrillation, atrial flutter, and sinus rhythm.

Additionally, HeartBeam’s AI engine has the potential to transform routine monitoring into predictive power in the future. The company’s platform enables frequent readings, building a unique longitudinal ECG dataset unique that no one else offers. By leveraging deep learning on the repeated measurements, there is an opportunity to develop predictive capabilities, such as screening for hidden cardiac conditions and forecasting risk of future events. The unique longitudinal dataset will create a defensible data moat as the company continues to advance its AI program.

Market Opportunity

HeartBeam is targeting a large unmet need in cardiac care by delivering hospital-grade ECG diagnostics to patients outside of traditional healthcare settings. Cardiovascular disease is the leading cause of death worldwide, yet most cardiac events occur at home, where standard 12-lead ECGs are not available, leading to costly delays in diagnosis and treatment. HeartBeam’s FDA-cleared 3D ECG technology is designed to close this critical gap with on-demand, remote diagnostic capabilities.

The company’s initial commercialization strategy focuses on two distinct U.S. entry markets. The first includes approximately 500,000 elevated-risk patients in concierge care settings, representing a $250 million to $500 million annual revenue opportunity. The second addresses a larger direct-pay segment of 2.6 million elevated-risk individuals, with potential revenues of $1.3 billion to $2.6 billion annually. Future expansion may include reimbursement-driven pathways through Medicare Advantage, providers, and payer partnerships.

HeartBeam anticipates annual subscription pricing between $500 and $1,000 per patient, with roughly 50% gross margins on device costs and 70%+ on recurring revenue. Based on a model using five U.S. regions, each with an estimated 75,000 eligible patients, HeartBeam projects that just 10% adoption would generate approximately $20 million in gross profit—enough to reach cash flow break-even under current pricing and margin assumptions. Over time, the company’s longitudinal ECG dataset and predictive AI capabilities are expected to deliver additional value to healthcare systems, research institutions, and life science partners.

Leadership Team

Robert Eno, Chief Executive Officer and Director, brings over 30 years of experience in the medical technology industry, including leadership roles at HeartFlow, OptiMedica, and NeoGuide Systems. He joined HeartBeam as President in January 2023 and was appointed CEO in October 2024, later joining the board in May 2025 to support commercial growth.

Branislav Vajdic, Ph.D., Founder and Chief Technology Officer, is a semiconductor and medtech innovator who previously led product design teams at Intel and founded NewCardio. He holds over 20 patents and is the original architect of HeartBeam’s core technology.

Tim Cruickshank, Chief Financial Officer, oversees financial strategy and capital allocation. He works closely with the leadership team to support commercialization while maintaining financial discipline aligned with key regulatory milestones.

Peter Fitzgerald, M.D., Ph.D., Chief Medical Advisor, is Director of the Center for Cardiovascular Technology at Stanford and a seasoned clinical trialist with over 175 studies and 650 publications. He has founded over 20 medtech companies and advises the FDA on digital health analytics.

Ken Persen, Chief Technology Officer, has more than 28 years of experience in cardiac rhythm management and digital health. He previously served as CTO and CEO at LIVMOR and held engineering roles at Cameron Health and Guidant.

Investment Considerations
  • HeartBeam has developed and secured FDA clearance for a credit card-sized 3D ECG device that enables arrhythmia assessment outside of traditional clinical settings.
  • The company’s 12-lead ECG synthesis software successfully met pivotal study endpoints and is currently under FDA review, supporting near-term commercialization.
  • HeartBeam’s AI algorithms, validated in collaboration with Mount Sinai, demonstrated high diagnostic accuracy and provide a foundation for predictive cardiac monitoring. The company plans to submit its AI algorithms for FDA clearance in the future.
  • The company holds more than 20 issued patents, including protections for device design and risk-based diagnostic algorithms.
  • HeartBeam was honored with the 2025 Innovation Award in Remote Cardiac Diagnostics, reinforcing its leadership position in the digital health space.

HeartBeam Inc. (NASDAQ: BEAT), closed Friday's trading session at $2.4, up 1.6949%, on 1,454,269 volume with 00 trades. The average volume for the last 3 months is 26,402,140 and the stock's 52-week low/high is $0.54/$4.

Recent News

Oncotelic Therapeutics Inc. (OTCQB: OTLC)

The QualityStocks Daily Newsletter would like to spotlight Oncotelic Therapeutics Inc. (OTCQB: OTLC).

Oncotelic Therapeutics (OTCQB: OTLC) is positioned at the heart of the evolving landscape of pharmaceutical innovation, applying ultra-small carrier technologies to elevate existing cancer therapies. "The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance of anticancer compounds," reads a recent article. "The advantages of nanoparticle delivery in pharma are significant… The contemporary view holds that nanocarrier-enabled formulations may be as transformative for drug delivery as the advent of monoclonal antibodies was for biologics… Into this context, Oncotelic Therapeutics, which in its most recent news has advanced nanoparticle-based delivery strategies through its joint venture entity, involving its Deciparticle(TM) platform. The company is now preparing its first-in-human study of an intravenous Everolimus (Afinitor(R)) nanoformulation (Sapu-003) that it codevelops via its subsidiary/partner Sapu Nano. According to the company, Sapu003 is designed to overcome the absorption and tumor-penetration limits of conventional oral Everolimus (Afinitor(R)) by delivering full bioavailability via intravenous nanoparticle delivery."

To view the full article, visit https://ibn.fm/VaID8

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration of artificial intelligence to accelerate discovery and regulatory workflows.

At the center of this foundation is Chairman and CEO Dr. Vuong Trieu, a prolific industry pioneer who has filed more than 500 patents with 75 issued patents across biologics, small molecules, nanoparticles, and diagnostics. Dr. Trieu co-invented Abraxane® (sold to Celgene for $2.9 billion), underscoring his track record of creating high-value therapies. Through collaborations with industry leaders and its stake in specialized joint ventures, Oncotelic is positioned to advance a diverse portfolio of oncology assets with greater speed and cost efficiency. The company also operates a proprietary AI platform, PDAOAI, which streamlines scientific writing, regulatory documentation, and data interpretation. This system is accessible to the public through a dedicated Discord server, offering real-time engagement with Oncotelic’s research ecosystem.

With expanded clinical activity and a next-generation development model, Oncotelic continues to evolve as a multi-asset innovator in precision oncology.

The company is headquartered in Agoura Hills, California.

Pipeline and Partnerships

Oncotelic’s lead candidate is OT-101, currently in a Phase 3 trial for pancreatic ductal adenocarcinoma (STOP-PC study) and evaluated in gliomas and metastatic solid tumors in combination with IL-2 and checkpoint inhibitors. The antisense molecule targets TGF-β2, a cytokine known to suppress immune responses and promote tumor growth. A Phase 1 trial combining OT-101 with IL-2 was recently completed, demonstrating safety and paving the way for combination therapies with PD-1 blockers and other immunotherapies.

Recent data have further strengthened the rationale for OT-101 in pancreatic ductal adenocarcinoma (PDAC). In June and July 2025, two peer-reviewed studies published in the International Journal of Molecular Sciences identified TGF-β2 gene expression and methylation status as significant prognostic markers in PDAC, particularly among younger patients and those with low CD8+ T-cell infiltration. High TGF-β2 expression correlated with reduced overall survival, while elevated TGF-β2 methylation was associated with improved outcomes. These findings validate TGF-β2 as a high-priority target and support the continued development of OT-101 as a precision therapy. Both studies leveraged Oncotelic’s proprietary AI-driven platform, PDAOAI, to mine and assemble multi-omic datasets, showcasing the system’s role in accelerating insight generation.

The company holds a 45% ownership stake in GMP Biotechnology Limited, a joint venture with Dragon Capital Overseas Limited. GMP Bio owns SAPU Bioscience, which is executing several pipeline programs. SAPU and Oncotelic are jointly utilizing a rapid IND platform through their partnership with Shanghai Medicilon to support regulatory filings for up to 20 drug candidates, with five INDs already underway. This collaboration is central to accelerating development of next-generation anticancer agents.

After the joint venture, Dr. Trieu, with his team, built out a state of the art and GMP-certified R&D facility in San Diego, which operates under SAPU, that manufactures clinical trial materials and supports a proprietary nanoparticle platform trademarked Deciparticle ™. This platform includes four therapeutic candidates—two of which are in late-stage manufacturing and expected to enter IND filing before the end of 2025.

Additionally, Oncotelic owns AL-101, an intranasal administered apomorphine product intended for the treatment of Parkinson’s disease, Erectile Dysfunction, and Female Sexual Disorders.

Market Opportunity

Oncotelic is targeting large and underserved therapeutic markets with significant commercial potentials. The global pancreatic cancer treatment market alone is projected to grow at a 12.3% CAGR, reaching $5.84 billion by 2030, up from $2.92 billion in 2024, according to Research and Markets. This growth is driven by increased disease prevalence, aging populations, and demand for more effective treatment options. Notably, the incidence of early-onset PDAC is rising at an estimated rate of 4% per year in the 15–34 age group, highlighting an emerging unmet need for targeted therapies among younger patients.

Beyond oncology, Oncotelic intends to develop AL-101 for Parkinson’s disease, which affects over 1 million patients in the U.S. alone and is expected to impact 1.2 million by 2030. Erectile Dysfunction and Female Sexual Dysfunction are also major global health issues, with Erectile Dysfunction affecting up to 70% of men over 60 and Female Sexual Dysfunction impacting approximately 40% of women—both with limited treatment options, particularly for patients who fail to respond to existing medications. These underserved populations offer fertile ground for innovative new therapies.

Leadership Team

Dr. Vuong Trieu is the Chairman and CEO of Oncotelic Inc. An accomplished innovator in pharmaceutical development, Dr. Trieu previously served as President and CEO of Igdrasol, where he pioneered the approval path for paclitaxel nanomedicine via a single bioequivalence trial. After Igdrasol merged with Sorrento Therapeutics, he became Chief Scientific Officer and a Board Director. He also held leadership roles at Cenomed, Abraxis, Applied Molecular Evolution, and Parker Hughes Institute. Dr. Trieu holds a Ph.D. in Molecular Microbiology, a B.S. in Botany, has published widely, and filed over 500 patent applications with 75 issued U.S. patents.

Amit Shah is the Chief Financial Officer of Oncotelic Inc. He has over 20 years of financial leadership in life sciences, including CFO roles at Marina Biotech and Igdrasol, and senior positions at ISTA Pharmaceuticals, Spectrum Pharmaceuticals, and Caraco. He also worked in consulting and ERP implementation. Mr. Shah holds a Bachelor of Commerce from the University of Mumbai, is an Associate Chartered Accountant in India, and is an inactive CPA in Colorado.

Dr. Anthony E. Maida III is the Chief Clinical Officer – Translational Medicine at Oncotelic Inc. He has over 25 years of experience advancing cancer immunotherapies and held senior roles at Northwest Biotherapeutics, PharmaNet, and Jenner Biotherapies. He has raised over $200 million for biotech firms and negotiated licensing deals with institutions such as Pfizer, Eli Lilly, and Yale. Dr. Maida holds dual B.A. degrees in Biology and History, an MBA, an M.A. in Toxicology, and a Ph.D. in Immunology, and is active in ASCO, AACR, and other scientific societies.

Investment Considerations
  • The company’s lead candidate, OT-101, is currently in a Phase 3 trial for pancreatic cancer and is advancing toward combination studies with checkpoint inhibitors.
  • A joint venture with GMP Biotechnology enables Oncotelic to conduct low-cost research and development, operate in-house GMP manufacturing, and support a rapidly expanding nanoparticle pipeline trademarked Deciparticle ™.
  • A strategic partnership with Shanghai Medicilon supports rapid IND filings for up to 20 drug candidates, significantly accelerating development timelines.
  • Oncotelic’s proprietary AI platform, PDAOAI, enhances regulatory and research workflows while offering public engagement tools for added transparency.
  • The company maintains a multi-indication pipeline spanning oncology, Parkinson’s disease, Erectile Dysfunjction and FemaleSexual Dysfunction, providing broad commercialization potentials.
  • Recent peer-reviewed publications support OT-101’s mechanism of action and spotlight TGF-β2 as a survival-linked biomarker in younger PDAC patients.

Oncotelic Therapeutics Inc. (OTCQB: OTLC), closed Friday's trading session at $0.0898, up 5.3991%, on 300,427 volume with 00 trades. The average volume for the last 3 months is 146,870 and the stock's 52-week low/high is $0.0242/$0.11.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings (OTCQB: NGTF) , dba as TechForce Robotics, recently announced that the company is developing and launching a proprietary beverage dispensing robotic system called BIM-E (Beverages in Motion – Everywhere). "The system is designed to optimize both beverage revenue and service efficiency and was created to address two major challenges faced by many venues: long wait times and lost revenue caused by insufficient staff during busy periods. It reduces beverage serve time and may help capture lost revenue that often occurs when there's not enough human servers to meet consumer demand," an article reads. "The Beverage Bot is engineered to dispense both carbonated beverages and beer with precision, and delivers cold beverages quickly, without sacrificing consistency or quality… The company expects the solution to be especially well-suited for environments where beverage serve speed and volume are required, such as at concerts, sporting events, conferences, festivals, airports, and many others."

To view the full article, visit https://ibn.fm/TE9RC

Nightfood Holdings Inc. (OTCQB: NGTF) is a hospitality technology and asset acquisition company revolutionizing hotel operations through AI-driven service robotics and strategic property acquisitions. By integrating advanced automation solutions with high-value hospitality assets, NGTF is setting a new standard for operational efficiency, cost reduction, and labor optimization in the hospitality industry.

With a focus on Robotics-as-a-Service (RaaS) and hotel ownership, NGTF is uniquely positioned at the intersection of technology and real estate, creating scalable, revenue-generating solutions that drive the widespread adoption of automation in the hospitality sector.

Operations

Nightfood Holdings is focused on two core business areas:

  • Hotel Acquisitions & Operations – NGTF is acquiring a portfolio of independent hospitality properties, spanning various market segments from midscale to luxury. These hotels serve as real-world testbeds for automation technologies, allowing NGTF to refine its RaaS solutions before deploying them at scale.
  • Robotics-as-a-Service (RaaS) for Hospitality – NGTF provides subscription-based, AI-driven robotic automation, designed to optimize hotel operations. By deploying standardized automation solutions, NGTF helps hotels reduce costs, improve labor efficiency, and enhance guest experiences.

Through this fully integrated model, NGTF ensures that its robotics solutions are tested, optimized, and proven profitable before expanding to third-party hotel operators.

Market Opportunity

The demand for automation in hospitality is accelerating, driven by labor shortages, rising costs, and increased competition. NGTF is positioned to capitalize on this shift through its combined hotel ownership and RaaS strategy.

  • Total Addressable Market (TAM): The global service robotics market is projected to reach approximately $107.75 billion by 2030, driven by widespread adoption across industries including hospitality, according to Research and Markets.
  • Serviceable Available Market (SAM): The global smart hospitality market, which includes AI and automation technologies for hotels, is projected to reach $186.10 billion by 2032, according to SNS Insider.
  • Competitive Positioning: NGTF’s unique real estate + automation model allows it to implement cost-saving robotics solutions in real-world environments before expanding adoption across the industry.

Industry Impact: The Future of Smart Hotels

NGTF is at the forefront of next-generation hospitality automation, transforming how hotels operate. By combining AI-powered service robotics with real estate acquisitions, NGTF is pioneering the transition to smart, highly efficient hotel environments.

Hotels acquired by NGTF serve as testing grounds for robotics deployment, allowing the company to continuously refine its automation solutions. The biggest industry benefits include:

  • Cost Savings for Hotel Operators – Reducing labor costs and improving operational efficiency.
  • Scalability & Standardization – Offering a streamlined, subscription-based RaaS model for seamless automation adoption.
  • Industry Leadership in Hotel Robotics – Driving the transformation of hospitality with AI-powered automation solutions.

Future Vision & Growth Strategy

Over the next three to five years, NGTF is committed to scaling both its hotel portfolio and RaaS adoption. By refining and optimizing its automation technologies in its own properties, NGTF will continue deploying RaaS to third-party hotel operators, positioning itself as a leader in next-generation hospitality automation.

Through strategic acquisitions and AI-driven solutions, NGTF is defining the future of smart hotels—delivering cost-efficient, scalable automation that reshapes the hospitality landscape.

Team Expertise as a Strategic Advantage

In addition to technology and real estate, NGTF’s most powerful asset is its team. The company’s leadership and operating partners bring deep expertise in both hospitality and food service, having collectively developed over 50 properties, managed more than 130 hotels, and supported more than 6,000 quick-service restaurants.

This wealth of experience enables NGTF to execute its automation and acquisition strategy with operational discipline, industry insight, and scale—further strengthening its position in next-generation hospitality.

Investment Considerations
  • Dual Growth Strategy – NGTF combines hotel acquisitions with AI-powered automation, creating an integrated model that maximizes operational efficiency and revenue potential.
  • Expanding Robotics-as-a-Service (RaaS) – Subscription-based robotic automation solutions designed to reduce operational costs and address labor shortages for hotel operators.
  • Strategic Hotel Acquisitions – Acquiring a variety of hospitality assets, from midscale to luxury, to serve as testing grounds for AI-driven automation and to drive profitability.
  • Proven Market Demand – Rising labor costs and increasing adoption of service robotics are fueling demand for automation in hospitality, positioning NGTF as an early leader in the sector.
  • Scalable & Revenue-Generating Model – By owning hotels and offering RaaS to third-party operators, NGTF is building a diversified, high-growth business model.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Friday's trading session at $0.055855, up 4.4019%, on 322,943 volume with 00 trades. The average volume for the last 3 months is 539,320 and the stock's 52-week low/high is $0.0053/$0.114.

Recent News

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising.

LaFleur Minerals Inc., a Canadian near-term gold producer, just announced the closure of a non-brokered hard dollar private placement yielding gross proceeds of $900,000

This follows the recently closed LIFE offering that yielded $4,695,000 and a Flow-Through offering that brought in $2,205,421, bringing total proceeds to $7,800,421

With these funds, LaFleur is set to commission and restart gold production operations at its wholly owned Beacon Gold Mine and Mill, which it acquired in Fall 2024

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is a Canadian gold exploration and development company advancing its district-scale Swanson Gold Project in Québec's prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company just marked a strategic inflection point as it transitions from exploration to near-term gold production and value creation. LaFleur just announced the closure of a non-brokered hard-dollar private placement for 1,800,000 units at $0.50 per unit, yielding gross proceeds of $900,000. This follows the recently closed LIFE offering, which yielded gross proceeds of $4,695,000, and the Flow-Through offering, which brought in $2,205,421 in gross proceeds ( https://ibn.fm/EZch9 ).

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

Investment Considerations
  • LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
  • The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
  • Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
  • LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
  • A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Friday's trading session at $0.3252, up 1.625%, on 144,038 volume with 00 trades. The average volume for the last 3 months is 393,360 and the stock's 52-week low/high is $0.0631/$1.65.

Recent News

Numa Numa Resources Inc.

The QualityStocks Daily Newsletter would like to spotlight Numa Numa Resources Inc.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

Numa Numa Resources was featured in a recent article that discussed its positioning as a key private-sector entity working on long-term development in Bougainville. "Numa Numa Resources is operating in one of the most geopolitically significant mining regions in the world, and recent diplomatic developments suggest that Bougainville's role in global resource security is drawing heightened international attention. As the United States engages more directly with Bougainville's leadership, the importance of the island's mineral wealth and its strategic location in the Pacific has become increasingly clear. For Numa Numa, an infrastructure developer and mining investor active in the Autonomous Region of Bougainville, this broader geopolitical spotlight reinforces the relevance of its long-term development plans in a region poised for major transformation."

To view the full article, visit https://ibn.fm/vsQVN

A recent analysis has determined that prices of gold dropped in the first trading sessions of the year, with spot gold dropping by over 4%. While prices did start the week at a low of $4,274 an ounce, they recovered slightly, increasing to $4,542 an ounce by the week's end. This is quite a decrease from the highs recorded last year when prices rose by almost 65% year-on-year. The rally was partly driven by decreasing inflation concerns and a weaker greenback. Expectations that the Fed would begin reducing rates of interest also helped drive the rally, with many expecting the Federal Reserve to cut rates at least twice this year. Latest figures show that China's gold reserves stand at 73.96 million ounces. Meanwhile, physical demand in Asia has shown improvement following the recent dip in prices. In China, local prices moved from a discount to a premium of about $3 an ounce over international spot prices, indicating stronger consumer interest. In India, dealers were also charging premiums of up to $15 an ounce above official domestic rates this week, a sharp turnaround from last week's discount of $61 per ounce. As the year progresses, many analysts, including those at firms like Numa Numa Resources Inc., will be watching how developments around the world impact the gold market. 

Numa Numa Resources Inc. is a mining and infrastructure development company focused on unlocking transformational opportunities in the Autonomous Region of Bougainville, where the company is headquartered and where its management has lived and worked for 10 years.

Bougainville, a resource-rich archipelago in the South Pacific, is perhaps best known as the home of the Panguna Mine. Developed by Rio Tinto, the Panguna Mine was the largest open cut copper and gold mine in the world when it operated from 1972 to 1989 before being shuttered due to a civil war, called “the Crisis,” between Bougainville and its parent government Papua New Guinea. In 2001, the Bougainville Peace Agreement ended the war and awarded Bougainville limited autonomy, including its own constitution, by which ownership of the mine reverted to its customary landowners. A majority of the Panguna Mine’s copper, gold, and silver ore resources remain within its walls, making the fully explored and developed Panguna Mine one of the largest ore bodies in the world, today worth approximately $100 billion. Most geologists who have studied Bougainville believe that other nearby locations such as Mainoki and Karato are highly prospective and may contain ore deposits similar in size and scale to those of the Panguna Mine.

Numa Numa’s fundamental strength is the relationships it has developed over the years with the landowners in the Panguna, Mainoki, and Karato resource areas.

Pursuant to newly executed written agreements, Numa Numa has formed and now owns a stake in three new corporate entities that will own and develop, with the Panguna, Mainoki, and Karato landowners, their respective resources as partners pursuant to the laws and regulations of Bougainville. One entity has been established for Panguna, one for Mainoki, and one for Karato. Each entity is co-owned with the landowners of those respective areas. Each owns all the landowners’ resource rights to that area, and each entity is to be managed by a joint company/landowner team led by Numa Numa. Due to Bougainville’s constitution and law, each of these entities therefore effectively controls the monetization of the resources in its area. In Bougainville, the landowners—not the government—own the resources. With the Panguna, Mainoki, and Karato landowners as its contractual partners, Numa Numa now expects to prosper significantly in its mining endeavors in Bougainville.

Numa Numa has a contractual agreement to develop the Panguna Mine executed both with the Panguna Mine Landowner Clan Chiefs—the governmentally accepted owners of the Panguna Mine—and the government of Bougainville and President Ishmael Toroama, along with its rights to the exploration licenses regarding Mainoki and Karato for which it has applied and is awaiting approval. The company will be pursuing all such rights through those corporate entities. Numa Numa, together with its landowner partners, fully expect that these entities will ultimately be issued licenses and approvals by the government to legally pursue mining activities in their respective areas. Together with the Panguna, Mainoki, and Karato landowners, Numa Numa then intends to partner with mining companies who are now being invited to explore, fully develop, and ultimately construct and operate these prime Bougainville mining opportunities.

These new assets distinguish Numa Numa from any other aspirants in Bougainville. No one has any similar entities or relationships with any landowners, even in non-prospective areas, and certainly nothing in Panguna, Mainoki, and Karato, described as the three most important mining areas of Bougainville. That said, Numa Numa also continues to develop a road system in Bougainville’s roadless mining region, a limestone quarry and calcination facility to supply lime to all of Bougainville’s mining operations, and an integrated electric utility to supply electricity to Bougainville.

Metals Market Opportunity

The Panguna Mine contains one of the world’s largest copper and gold ore bodies, but the size of the mine’s resource is only one of its favorable characteristics. The amount of resources in the Panguna Mine are beyond dispute. The mine’s reserves are proven, while most of the world’s major deposits waiting to be mined are not. The Panguna Mine itself is highly accessible and comes with developed infrastructure; much of the roads, port facilities, and other infrastructure built to service the Panguna Mine remain largely intact.

The Panguna Mine’s two most important metals—gold and copper—are, at current market prices, almost equally valuable. Together, the mine’s proven gold and copper resources underscore its role as a global tier-one asset.

Panguna’s 547.15 metric tons of known gold reserves equate to nearly 1% of all global reserves, with value estimates exceeding $40 billion. Given the growing interest by many nations in denominating their trade balances in something other than U.S. dollars, the price of gold has increased dramatically over the last two years, and no end is in sight.

As for copper, the global transition to electrification is triggering historic demand for it, yet the supply pipeline is critically constrained. According to RBC Dominion Securities, just four new large-scale copper mines are in development globally, while demand requires at least one new mine per year through 2035. The Panguna Mine’s copper reserves total 5.3 million metric tons—equal to roughly 70% of Canada’s total reserves—placing it in the same league as major copper-producing nations. With ore grades declining and permitting delays mounting worldwide, the Panguna Mine—let alone Mainoki and Karato when they are explored—is uniquely positioned to help fill the world’s looming copper supply gap.

Independence Requires Numa Numa Rebuilding the Panguna Mine—and Diplomacy

Bougainville is currently an autonomous region of Papua New Guinea, but the 2001 Bougainville Peace Agreement provided Bougainville with the right, within 20 years, to conduct an independence referendum. During this period, Bougainville’s current president, Ishmael Toroama, was the lead proponent in advocating Bougainvillean independence. In 2019, the independence referendum, in which registered Bougainvilleans were asked whether they wished to remain part of Papua New Guinea or become citizens of a new, independent country, was held, and 97.7% of the population chose independence. The next year, Ishmael Toroama was elected President of Bougainville.

Numa Numa assisted Toroama in both his independence initiatives and his presidential election. Both Numa Numa and President Toroama, as well as the great majority of Bougainvilleans, understand that Bougainvillean independence depends on having the means to pay for its cost.

Simply put, Bougainvillean independence depends on rebuilding the Panguna Mine. Bougainvilleans know that they cannot do it themselves. The people understand that, and identify Numa Numa’s business plan for rebuilding the Panguna Mine, as well as the support they assume will come from its Western affiliations—most of the company’s shareholders are either American or Canadian—as the key to not only their prosperity, but their freedom as well.

Bougainvilleans also back Numa Numa’s business plan because they fear the alternative: China, which covets not only Bougainville’s gold and copper, but its strategic location together with its deepwater port at Loloho, the best deepwater port in the Third Island Chain.

On the front line in the Western Pacific’s rising tensions between China and the U.S., Bougainvilleans far prefer an alliance with their tradition Western allies to a takeover by China. Numa Numa’s ongoing diplomatic engagement, including arranging recent visits to Washington D.C. with President Ishmael Toroama, positions the company as both an economic and strategic partner in shaping Bougainville’s future.

Leadership Team

John D. Kuhns, Chairman & Chief Executive Officer, founded Numa Numa Resources and has led the company since its formation in 2016. He previously founded China Hydroelectric Corporation, the largest foreign-owned electric power company in China, and listed the company on the NYSE. He has taken five other infrastructure and energy companies from initial concept to public listings and has owned and managed three Wall Street investment firms. He holds degrees from Georgetown University, the University of Chicago, and Harvard Business School and is also the author of four published novels.

Shadron L. Stastney, Vice-Chairman & Chief Operating Officer, joined Numa Numa Resources as a consultant in 2022 and became its Vice-Chairman and Chief Operating Officer in 2025. He was previously the co-founder of Vicis Capital, a multi-strategy hedge fund with peak assets of $6.8 billion. Before that, he was a Director and Head of the Hedging and Monetization Group at Credit Suisse First Boston, and a corporate attorney at Cravath, Swaine and Moore. He received his JD from Yale Law School and his BA from the University of North Dakota.

Anthony Dixon, Director, founded and was the CEO of Helios Renewable Energy Limited, a solar energy developer, and Metanoia, a sustainability auditor. He is also the Founder and Chairman of The Alliance for Sustainable Schools. His previous roles include CEO of ASB Biodiesel, Senior Advisor for Project Development in Asia with Canadian Solar; a Director of China Hydroelectric Corporation; Chief Operating Officer of ZEDFactory; and a Director of the Solar Electric Light Company. He was a Managing Director and Head of UK Capital Markets with Citigroup Global Markets; a Vice President with Salomon Brothers; and Director of Nikko Salomon Smith Barney in Tokyo, where he co-headed the firms’ securitization business. He holds a first-class honors degree in physics and a B.A. in philosophy from the University of Western Australia, an MBA from Harvard Business School, and a master’s degree in renewable energy engineering from Imperial College, London.

Mary E. Fellows, Director, has more than two decades of experience in renewable energy and infrastructure development. She previously served as EVP, Chief Compliance Officer, and Corporate Secretary of China Hydroelectric Corporation, and held leadership roles at GenSelf Corporation, Solar Electric Light Company, and New World Power Corporation. She holds a bachelor’s degree from Teikyo Post University and is a graduate of Harvard Business School’s AMP program.

Ian Smith, Director, is a mining engineering honors graduate from the University of Queensland, Australia. He has 60 years’ experience in the international mining industry, spanning functions including corporate management, operations, project management and engineering. Significantly, he was involved with the development of Bougainville’s Panguna copper-gold mine, from exploration, pre-production and startup to full production. The Panguna Mine at the time was the largest open pit copper-gold mine in the world. He was mine manager until he took another corporate responsibility in Mexico to develop the 72,000tpd La Caridad open pit copper mine. Additional operations and engineering experience include the 2,500 tpd CIL gold project in Uruguay and mining projects in Asia, South America, Africa, and the Pacific Rim.

Lawrence Queen, Senior Consulting Geologist, has over 35 years of experience in global mineral exploration, including five years as Principal Economic Geologist for the Geological Survey of Papua New Guinea. He holds a BSc from the New Mexico Institute of Mining and Technology and an MSc from the University of Alaska and is a long-standing member of both the Australasian Institute of Mining and Metallurgy and the Australian Institute of Geoscientists.

Tete Omas, Manager, Lakeville Mines, oversees operations at Numa Numa’s mining subsidiary and brings deep, hands-on experience in gold mining and equipment fabrication. A second-generation miner, he previously served in the PNG Mineral Resource Authority’s Small Scale Mining Branch and began his career working on his family’s mining lease at Mt. Kaindi.

Seeking Investors: Intention to Go Public Soon

Numa Numa is seeking investors—strategic and financial—to be partners in its world-class, resource-rich Bougainville opportunity. The company’s goal is to not only be the leading mining entity in Bougainville, but to become the country’s leading commercial enterprise as well.

Numa Numa is currently a privately held corporation but is exploring means of going public so as to list its shares on one or more international stock exchanges and provide its shareholders with liquidity.

Recent News

chart

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

Ucore reports preparations for heavy rare earth element ("REE") processing at its Strategic Metals Complex in Alexandria, Louisiana, with a goal of commissioning the first commercial RapidSX(TM) separation unit in mid-2026.

RapidSX is Ucore's proprietary REE separation platform designed to improve on conventional solvent extraction processes.

Ucore's broader mission is to establish a resilient, vertically integrated REE supply chain in North America.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is signaling a major leap forward in the race to establish a secure Western supply chain for heavy rare earth elements, with plans ramping up for commercial operations targeted in Louisiana by 2026. The company recently released detailed information about significant progress on its proprietary rapid-separation technology and its transition from demonstration testing in Canada toward full deployment at a U.S. facility that could help reduce longstanding dependencies on foreign processors. The announcement underscores not only technological advancement but also strategic alignment with North American critical-mineral security goals.

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Friday's trading session at $5.16, up -0.5780347%, on 429,625 volume with 00 trades. The average volume for the last 3 months is 688,920 and the stock's 52-week low/high is $0.4445/$10.69.

Recent News

GlobalTech Corp. (OTC: GLTK)

The QualityStocks Daily Newsletter would like to spotlight GlobalTech Corp. (OTC: GLTK).

As enthusiasm around AI continues to propel share prices to record levels, a growing number of investors are asking a familiar question: Is the market heading toward another speculative bubble, or is this simply the early stage of a lasting shift? History suggests the answer is rarely straightforward. U.S. stocks posted another strong year in 2025, with the S&P 500 surging 16%. Much of that advance came from companies most closely tied to AI, including Microsoft, Broadcom, Nvidia, and Alphabet. Their gains have helped push major indexes to record levels, but they have also intensified concerns about how much money is being poured into AI infrastructure. Perhaps most telling is the level of scrutiny. Mentions of a potential AI bubble surged late last year, fueled by warnings from high-profile investors and central bankers. Surveys show that many fund managers view AI-related stocks as the market's most crowded tradeThat scrutiny, analysts say, may act as a stabilizing force. Unlike the unchecked optimism of the dot-com boom, today's debate includes serious questions about returns, debt, and long-term demand. For investors who are becoming overly concerned about a growing AI "bubble," smaller AI firms like GlobalTech Corp. (OTC: GLTK) could offer a hedge if due diligence reveals that the companies' fundamentals meet the investors' portfolio criteria. 

GlobalTech Corp. (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (AI), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.

GlobalTech’s diversified portfolio spans AI-powered solutions for enterprise productivity, e-commerce, retail, digital lending, compliance, and other high-growth domains. Flagship platforms include ThrivoAI, Cadnz, Baseball Blitz, Talina, ProtoEd, BillCare, Giftio, and EntityScan. The company also holds a majority stake in WorldCall Telecom Ltd., extending its telecommunications presence in Pakistan and supporting infrastructure-led value creation.

To strengthen market reach, GlobalTech continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. Its partnership with significant regional players like Omantel anchors growth in the Middle East, a key gateway market. At the same time, the company’s Center of Excellence (CoE) and #GTCTalks knowledge platform position it as a thought leader in emerging technologies.

Supported by a seasoned leadership team and a disciplined execution model, GlobalTech is building sustainable momentum across global AI and big data markets, with the governance, innovation, and agility required to capture outsized opportunities in the digital economy.

Investment Considerations
  • GlobalTech balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.
  • The company’s flagship platforms span multiple high-growth domains including enterprise productivity, e-commerce, digital lending, and compliance.
  • Its majority stake in WorldCall Telecom Ltd. supports infrastructure-led value creation in Pakistan’s telecommunications sector.
  • Strategic alliances with regional players such as Omantel anchor GlobalTech’s expansion into key international markets like the Middle East.

GlobalTech Corp. (OTC: GLTK), closed Friday's trading session at $1.9371, up -3.145%, on 700 volume with 00 trades. The average volume for the last 3 months is 180 and the stock's 52-week low/high is $1.1/$3.4.

Recent News

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix (NASDAQ: SNGX) is a New Jersey-based biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need. The company recently received updated analysis from Zacks Small-Cap Research following its announcement that milestone enrollment had been reached in the ongoing confirmatory Phase 3 FLASH2 trial of HyBryte(TM). The study focuses on the treatment of cutaneous T-cell lymphoma, with the overall blinded response rate standing at 48% for patients who have completed treatment. "In the Nov. 20, 2025, research report published by Zacks Small-Cap Research, expert analysis indicated strong conviction about the 50-patient enrollment milestone and encouraging clinical results while noting puzzlement at the market's subdued response. The report maintains Zacks' $25 per share valuation for Soligenix, based on a probability-adjusted discounted cash flow model that considers potential future revenues from the company's product pipeline, including HyBryte, SGX302 and SGX945," reads an article discussing the company. "Looking ahead, the second quarter 2026 interim analysis represents the next major catalyst for Soligenix. The Zacks report expresses confidence that the trial is trending in the right direction based on the 48% blinded response rate, stating that ‘this update gives us a lot of confidence that the trial is at the very least trending in the right direction.' With no changes to the financial model following the enrollment milestone, the valuation remains at $25 per share, representing the report's view that the risk-reward profile remains attractive for investors willing to accept the inherent uncertainties of late-stage clinical development."

To view the full article, visit https://ibn.fm/e9XQ5

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Investment Considerations
  • Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
  • The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
  • Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
  • The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
  • Soligenix is led by an experienced management team with a strong track record of success.

Soligenix Inc. (NASDAQ: SNGX), closed Friday's trading session at $1.35, up -6.25%, on 147,874 volume with 00 trades. The average volume for the last 3 months is 403,475 and the stock's 52-week low/high is $1.09/$6.2299.

Recent News

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI (NASDAQ: DVLT) highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform, a GPU-powered, zero-trust edge infrastructure designed to enable instant data monetization with national security-grade cybersecurity. The deployment integrates SanQtum AI Enterprise Units directly into Datavault AI's patented Information Data Exchange, DataScore, and Datavalue AI agents, allowing real-time data scoring, tokenization at birth, and enterprise-grade AI processing without reliance on public cloud infrastructure. Company estimates indicate an addressable market exceeding $2 billion in each metropolitan region, driven by strong demand across insurance and financial services applications including real-time data tokenization, AI workloads, secure verification, and private micro-exchanges, positioning Datavault AI for significant recurring revenue opportunities as part of its planned multi-city expansion.

To view the full press release, visit https://ibn.fm/ByBuR

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Investment Considerations
  • WiSA Technologies is strategically positioned in the rapidly growing market for wireless and immersive audio solutions, with strong partnerships with leading consumer electronics brands like Samsung, LG, and Bang & Olufsen.
  • The company’s proprietary WiSA E technology is driving innovation in home entertainment, offering a scalable platform that supports advanced audio formats such as Dolby Atmos and DTS:X.
  • WiSA Technologies’ recent licensing agreements with major HDTV brands covering 43% of the Android OS market significantly expand its market reach and revenue potential.
  • Led by an experienced management team with deep industry knowledge, WiSA Technologies is well-equipped to capitalize on the increasing demand for high-quality, wireless audio experiences.
  • With a focus on setting industry standards through the WiSA Association, the company is positioned as a leader in the evolving audio technology landscape, providing a strong foundation for long-term growth.
Additional Resources

Datavault AI Inc. (NASDAQ: DVLT), closed Friday's trading session at $0.9163, up -9.2772%, on 158,135,083 volume with 00 trades. The average volume for the last 3 months is 88,981,873 and the stock's 52-week low/high is $0.2512/$4.1.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.